Back to today’s briefing

Story perspectives

Revolutionary NMDA Receptor Discovery Could Transform Antidepressants

2/15/2025

32 3

Summary

Story summary

Groundbreaking research has unveiled the NMDA receptor subtype GluN1-2B-2D in mammalian brains, shedding light on ketamine's binding mechanisms. Through advanced electron cryo-microscopy, scientists discovered various binding sites that could reshape brain activity. This pivotal discovery paves the way for developing safer antidepressants, potentially alleviating worries surrounding ketamine's side effects.

1 of 1

Story summary

Groundbreaking research has unveiled the NMDA receptor subtype GluN1-2B-2D in mammalian brains, shedding light on ketamine's binding mechanisms. Through advanced electron cryo-microscopy, scientists discovered various binding sites that could reshape brain activity. This pivotal discovery paves the way for developing safer antidepressants, potentially alleviating worries surrounding ketamine's side effects.